Sinusitis
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- An acute or chronic inflammatory process affecting the mucous membranes of any sinus cavity.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Sinusitis
- Therapeutic area
- Pulmonology
- sinusitis
- Sinusitis Recurrent
- Disease mechanisms
- Inflammatory
Sources for recorded values
- Severity
- Mild
- Pulmonology
- Rheumatology
Sources for recorded values
- MONDO ID
- MONDO:0005961
- Parent condition
- MONDO:0001735
Related records
Broader conditions (13)
- Bone disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Inflammatory disease
- Musculoskeletal system disorder
- Nasal disorder
- Otorhinolaryngologic disease
- Paranasal sinus disorder
- Respiratory system disorder
- Skeletal system disorder
- Skull disorder
Narrower conditions (13)
- Acute ethmoiditis
- Acute frontal sinusitis
- Acute maxillary sinusitis
- Acute sphenoidal sinusitis
- Chronic ethmoidal sinusitis
- Chronic frontal sinusitis
- Chronic maxillary sinusitis
- Chronic rhinosinusitis
- Chronic sphenoidal sinusitis
- Ethmoid sinusitis
- Frontal sinusitis
- Maxillary sinusitis
- Sphenoid sinusitis
Trials (216)
- "Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study".
- 15-Degree Tilt, Head Up, Feet Down Body Position for Sinus Surgery Patients
- 3D Printing to Improve Nasal Irrigation Outcome
- A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
- A Comparison Between Co-phenylcaine Nasal Spray and Nasal Nebulization Prior to Rigid Nasoendoscopic Examination
- A Comparison of the Safety and Efficacy of Two Different Regimens of Levofloxacin in the Treatment of Acute Bacterial Sinusitis(Sinus Infection) in Adults.
- A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
- A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction
- A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage
- A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
- A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses
- A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
- A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
- A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.
- A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
- A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
- A Trial of Point of Care Information in Ambulatory Pediatrics
- A User Study of SYNUS Pain Relief Made by Tivic Health Systems
- Acupuncture and Herbal Treatment of Chronic HIV Sinusitis
- Adherence in Global Airways
Approved drugs (27)
- Amoxicillin
- Azithromycin
- Azithromycin monohydrate
- Brompheniramine maleate
- Carbetapentane citrate
- Cefprozil, (E)-
- Cefuroxime axetil
- Chlorpheniramine maleate
- Ciprofloxacin
- Clarithromycin
- Clavulanate potassium
- Dextromethorphan hydrobromide
- Dupilumab
- Epinephrine
- Garenoxacin mesylate
- Guaifenesin
- Lascufloxacin
- Levofloxacin
- Moxifloxacin hydrochloride
- Naphazoline hydrochloride
Drugs in development (45)
- Acetaminophen Phase 2
- Acetylcysteine Phase 3
- Bacitracin Phase 2
- Beclomethasone dipropionate Phase 3
- Benralizumab Phase 2
- Betamethasone dipropionate Phase 2
- Budesonide Phase 3
- Bupivacaine Phase 1
- Clavulanic acid Phase 3
- Dexamethasone Phase 1
- Dornase alfa Phase 3
- Esmolol Phase 2
- Etokimab Phase 2
- Fluticasone propionate Phase 3
- Honey Phase 1
- Ibuprofen Phase 2
- Itraconazole Phase 2
- Ivacaftor Early phase 1
- Labetalol Phase 2
- Lactobacillus acidophilus Phase 2
Other linked drugs (2)
- Dexmedetomidine
- Remifentanil